Yonit Marcus, Ph.D. - Publications

Affiliations: 
2010 Weizmann Institute of Science, Rehovot, Israel 
Area:
Histology Biology, Physiology Biology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, Nevo N, Biton I, Bach M, Berkutzki T, Fridkin M, Benayahu D, Shechter Y, Stern N. Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes. 62: 1121-30. PMID 23250359 DOI: 10.2337/Db12-0792  0.503
2012 Shechter Y, Sasson K, Marcus Y, Rubinraut S, Lev-Goldman V, Fridkin M. Establishing the principle of reversibility in peptide/protein and small-molecule therapy. Therapeutic Delivery. 3: 17-23. PMID 22833930 DOI: 10.4155/Tde.11.133  0.504
2010 Sasson K, Marcus Y, Lev-Goldman V, Rubinraut S, Fridkin M, Shechter Y. Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 214-20. PMID 19883707 DOI: 10.1016/J.Jconrel.2009.10.028  0.524
2008 Marcus Y, Sasson K, Fridkin M, Shechter Y. Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin. Journal of Medicinal Chemistry. 51: 4300-5. PMID 18578475 DOI: 10.1021/Jm8002558  0.511
2008 Shechter Y, Mironchik M, Rubinraut S, Tsubery H, Sasson K, Marcus Y, Fridkin M. Reversible pegylation of insulin facilitates its prolonged action in vivo. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 70: 19-28. PMID 18495444 DOI: 10.1016/J.Ejpb.2008.03.018  0.523
Show low-probability matches.